Stratatech Corporation Report issue

For profit Phase 1
Founded: Madison WI United States (2000)
Status: Acquired by Mallinckrodt (2013) (2016)

Organization Overview

First Clinical Trial
2019
NCT04134143
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Stratatech, a Mallinckrodt Company | Stratatech Corporation

Active Ingredients

Drugs in Phase 1 Trials (1)

expressgraft-c9t1 skin tissue (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetic Foot (Phase 1)

Foot Ulcer (Phase 1)

Ulcer (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1